InvestWiser

OssDsign AB

OSSDNasdaq StockholmHealthcareMarket value 354 m SEK
3.20SEK −3.9%
last day · Price as of 18 November 2026

The answer first

Does OssDsign beat the market?

No, OssDsign has not beaten the market over the last year.

OssDsign−70.8%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 25% of Nordic stocks

    • Quality73
    • Value33
    • Trend10

    No. 118 of 195 in healthcare

Max for seven days

Follow OssDsign with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on OssDsign

From today, at a price of 3.20 SEK. Write why you follow OssDsign, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about OssDsign

Your first answer is free, no account needed.

Do you own OssDsign, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with OssDsign and a few more. Free, no card.

Past year against the exchange and Super Stock
OssDsign−70.8%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • OssDsign has fallen 70.8% over the past year, including dividends.
  • Overall, OssDsign ranks better than 25% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 80.7%. The price is 83.1% below its peak now.

What do analysts think of OssDsign?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

25

Quality, value and trend together. Better than 25% of Nordic stocks.

No. 118 of 195 in healthcare

Quality73
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 76 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.00
  • Asset turnoverSales divided by everything the company owns0.43
  • Return on equityProfit divided by equity−18.0%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value33
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 67 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity1.2
  • P/SPrice divided by sales2.2
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend10
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 153 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−20.5%
  • 6 months−22.4%
  • 9 months−50.3%
  • 12 months−70.8%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−0.8%
3 years, per year
−20.0%
5 years, per year
−17.3%
Year to date
−71.8%
Largest fall, 3 years
−80.7%
From a peak to the bottom
From the peak now
−83.1%
How far the price is from the peak
Volatility, 1 year
69.9%
How much the price swings over a year
Beta, 1 year
−0.01
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own OssDsign

One fund we follow owns OssDsign. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About OssDsign

OssDsign AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 38 employees.

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.

See the full analysis of OssDsign.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market